Wen Cao

509 citations
21 papers · 370 indexed · 1 hit paper · h-index 10
Topics
RNA modifications and cancer (4 papers)Liver physiology and pathology (3 papers)Epigenetics and DNA Methylation (3 papers)
Partner nations
ChinaUnited Kingdom

In The Last Decade

Wen Cao

18 papers receiving 368 citations

Hit Papers

ABCF1-K430-Lactylation promotes HCC malignant progression...202520262025102030

Peers

Wen Cao
Comparison fields: 5 of 69
  • Molecular Biology 162
  • Cancer Research 97
  • Plant Science 44
  • Pulmonary and Respiratory Medicine 43
  • Oncology 42
Replace Yi Tan with:
Yi Tan China
Jiahuan Yang China
Xiaoyan Dang China
Xiaoqin La China
Wen Shan China
Ramakrishna Chintala India
Lichao Zhang China
Jianqiong Yang China
Wen Cao relative to Yi Tan China Yi Tan's profile →
Citations per field
00.5×
Yi Tan · 1×
Citations per year

Countries citing papers authored by Wen Cao

Since Specialization
Citations

This map shows the geographic impact of Wen Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Cao more than expected).

Fields of papers citing papers by Wen Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Cao. The network helps show where Wen Cao may publish in the future.

Co-authorship network of co-authors of Wen Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Wen Cao. A scholar is included among the top collaborators of Wen Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen Cao. Wen Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 2
3
ABCF1-K430-Lactylation promotes HCC malignant progression via transcriptional activation of HIF1 signaling pathwaybreakdown →
31
4 0
5 9
6 4
7 0
8 3
9 63
10 4
11 11
12 37
13 6
14 18
15 30
16 16
17 14
18 92
19 25
20 1

About Wen Cao

Wen Cao is a scholar working on Cancer Research, Biological Psychiatry and Hepatology, having authored 21 papers that have together received 370 indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), Liver physiology and pathology (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Cancer Research (97 citations), Biochemistry (27 citations) and Molecular Medicine (16 citations). Wen Cao has collaborated with scholars based in China and United Kingdom. Frequent co-authors include Chao Hu, Lingling Wu, Hongbing Zhou, Haixin Qian, Hong‐Gang Wang, Yuan Yin, Jianping Wu, Xuerong Zhang, Jie Yu and Lutan Zhou. Their work appears in journals such as Carbohydrate Polymers, International Journal of Radiation Oncology*Biology*Physics and Cell Death and Differentiation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026